XXR Launch-What Needs To Change? Suggestions?

[Anonymous]

I am with Cadence. If they made us sell that shit drug, I would leave right away.

Who cares????

 

[Anonymous]

SIMPLE SOLUTION. FIRE SC and bring back GM!

Agree

 

[Anonymous]

I am with Cadence. If they made us sell that shit drug, I would leave right away.

Go ahead!

 

[Anonymous]

They need to terminate all of the remaining MNK legacy reps and merge these territories into those already filled with Inventiv reps.

They should also layoff any Inventiv reps without any XXR scripts and merge these territories also.

Next move is to terminate the MNK Regional Managers and DMs and replace them with contract employees.

Start looking for a co-promote opportunity with a big pharma partner.

Get the Pennsaid 2% samples on board like yesterday in order to gain access to the orthopods who Rx the long term high value XXR scripts.

Might be time for a mgmt and marketing reset.

In light of the FDA scrutiny of Questcor and UHC shooting down 4 out of 5 Acthar Gel leading indications, pull the plug on the acquisition and look elsewhere for a more suitable bolt on drug/organization.

Good luck holding on to the share gains MT. Once analysts get wind of what's going down with the XXR debacle, the Ofirmev price spike and hospitals booting it off formularies, the Questcor meltdown, well MNK stock could be in for a free fall.

Hope urgent action is taken to preserve jobs and enable the organization to turn it around.

There are several Regional Manager openings on questcor site now posted, if laid off, you might want to look there. Experienced managers are always in high demand.

 

[Anonymous]

I disagree. This drug is useful, but almost exclusively in the surgical arena.

So, after saying that, they should leave us alone and let us to after any and all surgical specialties, without a list of 125 targets. Just leave us alone and let us find the business with a list of surgeons and Percocet writing history! It will take some time for us to get traction in this market selling a CII!

I want to succeed. I am doing my job. Treat me like a professional adult. Give me the tools and let me show you what I can do.

You're right regarding the surgical arena. However, this drug lacks dosing flexibility. This one size fits all dosing doesn't fly in real world clinical. I think it's one of the main reasons it's not taking off as quickly.

 

[Anonymous]

Totally agree. Very confusing. Compounded by the marketing pieces